Provided by Tiger Trade Technology Pte. Ltd.

BioPharmX

0.5100
0.0000
Volume:- -
Turnover:- -
Market Cap:9.32M
PE:-0.68
High:0.5100
Open:0.5100
Low:0.5100
Close:0.5100
52wk High:1.18
52wk Low:0.2500
Shares:18.28M
Float Shares:16.07M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7497
EPS(LYR):-0.7497
ROE:-2020.23%
ROA:-209.33%
PB:13.00
PE(LYR):-0.68

Loading ...

Mar 23, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 18, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, item 5.02
Jan 30, 2020

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Jan 29, 2020

Major Issues Report

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
Jan 29, 2020

Business Combinations

Prospectuses and communications, business combinations
Jan 15, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 10, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Dec 10, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 20, 2019

Major Issues Report

Current report, items 3.01 and 9.01
Sep 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 17, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Jul 11, 2019

Major Issues Report

Current report, item 5.07
Jun 27, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jun 25, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Jun 11, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 11, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 16, 2019

Major Issues Report

Current report, items 1.01 and 9.01